Compass Therapeutics, Inc. (CMPX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
No signals recorded in the last 12 months.
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-29 | Lerner Neil | officer | P | 15,000 | 1.89 | $28,350 |
| 2026-04-29 | Anderman Jonathan | officer | P | 25,000 | 1.89 | $47,250 |
| 2026-04-29 | Anderman Jonathan | officer | A | 25,000 | 1.89 | $47,250 |
| 2026-04-29 | Lerner Neil | officer | A | 15,000 | 1.89 | $28,350 |
| 2026-04-29 | Lerner Neil | officer | P | 15,000 | 1.89 | $28,350 |
| 2026-04-29 | Anderman Jonathan | officer | P | 25,000 | 1.89 | $47,250 |
| 2026-04-29 | Anderman Jonathan | officer | A | 25,000 | 1.89 | $47,250 |
| 2026-04-29 | Lerner Neil | officer | A | 15,000 | 1.89 | $28,350 |
| 2026-02-08 | Schuetz Thomas J. | director | F | 36,687 | 6.52 | $239,199 |
| 2026-02-08 | Schuetz Thomas J. | director | F | 36,687 | 6.52 | $239,199 |
| 2026-01-09 | Schuetz Thomas J. | director | F | 46,777 | 5.35 | $250,257 |
| 2026-01-09 | Schuetz Thomas J. | director | F | 46,777 | 5.35 | $250,257 |
| 2026-01-02 | Shin Barry | officer | A | 125,000 | 5.17 | $646,250 |
| 2026-01-02 | Schuetz Thomas J. | director | A | 250,000 | 5.17 | $1,292,500 |
| 2026-01-02 | Lerner Neil | officer | A | 62,500 | 5.17 | $323,125 |
| 2026-01-02 | Anderman Jonathan | officer | A | 150,000 | 5.17 | $775,500 |
| 2026-01-02 | Shin Barry | officer | A | 125,000 | 5.17 | $646,250 |
| 2026-01-02 | Schuetz Thomas J. | director | A | 250,000 | 5.17 | $1,292,500 |
| 2026-01-02 | Lerner Neil | officer | A | 62,500 | 5.17 | $323,125 |
| 2026-01-02 | Anderman Jonathan | officer | A | 150,000 | 5.17 | $775,500 |
| 2025-11-16 | Schuetz Thomas J. | director | F | 44,025 | 4.83 | $212,641 |
| 2025-11-16 | Schuetz Thomas J. | director | F | 44,025 | 4.83 | $212,641 |
| 2025-05-27 | Schuetz Thomas J. | director | P | 10,000 | 2.11 | $21,100 |
| 2025-05-27 | Schuetz Thomas J. | director | P | 10,000 | 2.11 | $21,100 |
| 2025-04-09 | GORDON CARL L | director | S | 3,571,428 | 1.59 | $5,678,571 |
| 2025-04-09 | OrbiMed Capital GP VI LLC | director | S | 3,571,428 | 1.59 | $5,678,571 |
| 2025-04-09 | GORDON CARL L | director | S | 3,571,428 | 1.59 | $5,678,571 |
| 2025-04-09 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC | director | S | 3,571,428 | 1.59 | $5,678,571 |
| 2025-04-07 | Anderman Jonathan | officer | P | 20,000 | 1.54 | $30,800 |
| 2025-04-07 | Lerner Neil | officer | P | 20,000 | 1.42 | $28,400 |
| 2025-04-07 | Anderman Jonathan | officer | P | 20,000 | 1.54 | $30,800 |
| 2025-04-07 | Lerner Neil | officer | P | 20,000 | 1.42 | $28,400 |
| 2025-02-08 | Schuetz Thomas J. | director | F | 41,687 | 3.5 | $145,905 |
| 2025-02-08 | Schuetz Thomas J. | director | F | 41,687 | 3.5 | $145,905 |
| 2025-01-09 | Schuetz Thomas J. | director | F | 58,054 | 1.86 | $107,980 |
| 2025-01-09 | Schuetz Thomas J. | director | F | 58,054 | 1.86 | $107,980 |
| 2024-12-09 | Shin Barry | officer | A | 400,000 | 1.65 | $660,000 |
| 2024-12-09 | Shin Barry | officer | A | 400,000 | 1.65 | $660,000 |
| 2024-02-08 | Bisker-Leib Vered | director | F | 49,198 | 1.45 | $71,337 |
| 2024-02-08 | Schuetz Thomas J. | director | F | 44,782 | 1.45 | $64,934 |
| 2024-01-09 | Bisker-Leib Vered | director | A | 1,753,125 | 1.93 | $3,383,531 |
| 2024-01-09 | Schuetz Thomas J. | director | A | 637,500 | 1.93 | $1,230,375 |
| 2023-11-17 | Bisker-Leib Vered | officer | F | 64,415 | 1.5 | $96,623 |
| 2023-11-17 | Schuetz Thomas J. | director | F | 44,025 | 1.5 | $66,038 |
| 2023-03-10 | Schuetz Thomas J. | director | P | 10,000 | 3.37 | $33,700 |
| 2023-02-27 | Schuetz Thomas J. | director | P | 20,000 | 3.98 | $79,600 |
| 2023-02-15 | Schuetz Thomas J. | director | P | 20,000 | 3.86 | $77,200 |
| 2023-02-08 | Schuetz Thomas J. | director | A | 500,000 | 0 | $0 |
| 2023-02-08 | Bisker-Leib Vered | officer | A | 400,000 | 0 | $0 |
| 2023-01-31 | Schuetz Thomas J. | director | P | 20,000 | 4.05 | $81,000 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-22 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-07 SCHEDULE 13G
- 2026-08-06 10-Q
- 2026-08-06 8-K
- 2026-07-01 8-K
- 2026-06-23 8-K
- 2026-06-11 8-K
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-05 10-Q
- 2026-05-05 8-K
- 2026-04-30 4/A
- 2026-04-30 4/A
- 2026-04-29 4
- 2026-04-29 4
- 2026-04-29 ARS
- 2026-04-29 DEFA14A
- 2026-04-29 DEF 14A
- 2026-04-27 8-K
- 2026-03-12 S-8